These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2717665)

  • 1. Dopaminergic and serotoninergic influence on duration discrimination and vigilance.
    Rammsayer T
    Pharmacopsychiatry; 1989 Feb; 22 Suppl 1():39-43. PubMed ID: 2717665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ; Gobert A; Newman-Tancredi A; Audinot V; Lejeune F; Rivet JM; Cussac D; Nicolas JP; Muller O; Lavielle G
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1341-55. PubMed ID: 9732398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are there dissociable roles of the mesostriatal and mesolimbocortical dopamine systems on temporal information processing in humans?
    Rammsayer TH
    Neuropsychobiology; 1997; 35(1):36-45. PubMed ID: 9018022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat.
    Gobert A; Rivet JM; Lejeune F; Newman-Tancredi A; Adhumeau-Auclair A; Nicolas JP; Cistarelli L; Melon C; Millan MJ
    Synapse; 2000 Jun; 36(3):205-21. PubMed ID: 10819900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of dopamine (DA)/serotonin (5-HT)/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist.
    Dhir A; Kulkarni SK
    Brain Res Bull; 2007 Sep; 74(1-3):58-65. PubMed ID: 17683790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin decreases generation of dopaminergic neurons from mesencephalic precursors via serotonin type 7 and type 4 receptors.
    Parga J; Rodriguez-Pallares J; Muñoz A; Guerra MJ; Labandeira-Garcia JL
    Dev Neurobiol; 2007 Jan; 67(1):10-22. PubMed ID: 17443768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
    Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
    Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic and serotonergic mechanisms of thermoregulation: mediation of thermal effects of apomorphine and dopamine.
    Yamawaki S; Lai H; Horita A
    J Pharmacol Exp Ther; 1983 Nov; 227(2):383-8. PubMed ID: 6631720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
    Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
    J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of dopamine and serotonin in the discriminative stimulus effects of lisuride.
    White FJ; Appel JB
    J Pharmacol Exp Ther; 1982 May; 221(2):421-7. PubMed ID: 7077537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotoninergic effects on sensory and motor responses in extraverts and introverts.
    Netter P; Rammsayer T
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():21-6. PubMed ID: 2492574
    [No Abstract]   [Full Text] [Related]  

  • 12. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
    Monti JM; Jantos H
    Prog Brain Res; 2008; 172():625-46. PubMed ID: 18772053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states.
    Millan MJ; Newman-Tancredi A; Audinot V; Cussac D; Lejeune F; Nicolas JP; Cogé F; Galizzi JP; Boutin JA; Rivet JM; Dekeyne A; Gobert A
    Synapse; 2000 Feb; 35(2):79-95. PubMed ID: 10611634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist.
    Leggio GM; Cathala A; Neny M; Rouge-Pont F; Drago F; Piazza PV; Spampinato U
    J Neurochem; 2009 Oct; 111(2):614-23. PubMed ID: 19702657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine and noradrenaline content in fish retina: modulation by serotonin.
    Jaffé EH; Urbina M; Ayala C; Drujan Y; Drujan BD
    J Neurosci Res; 1987; 18(2):345-51. PubMed ID: 3694716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auditory temporal processing in Parkinson's disease.
    Guehl D; Burbaud P; Lorenzi C; Ramos C; Bioulac B; Semal C; Demany L
    Neuropsychologia; 2008; 46(9):2326-35. PubMed ID: 18439632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No effects of l-dopa and bromocriptine on psychophysiological parameters of human selective attention.
    Oranje B; Gispen-de Wied CC; Westenberg HG; Kemner C; Verbaten MN; Kahn RS
    J Psychopharmacol; 2006 Nov; 20(6):789-98. PubMed ID: 16478755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of amphetamine and haloperidol on temporal reproduction: dopaminergic regulation of attention and clock speed.
    Lake JI; Meck WH
    Neuropsychologia; 2013 Jan; 51(2):284-92. PubMed ID: 22982605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endurance performance in humans: the effect of a dopamine precursor or a specific serotonin (5-HT2A/2C) antagonist.
    Meeusen R; Roeykens J; Magnus L; Keizer H; De Meirleir K
    Int J Sports Med; 1997 Nov; 18(8):571-7. PubMed ID: 9443587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vivo effects of the 1,2,4-piperazine derivatives MM5 and MC1, putative 5-HT agonists, on dopamine and serotonin release in rat prefrontal cortex.
    Iskra-Jopa J; Gołembiowska K; Dziubina A; Cybulski M; Duszyńska B; Chilmonczyk Z
    J Pharm Pharmacol; 2005 Feb; 57(2):205-11. PubMed ID: 15720784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.